Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
On June 22, the Senate Commerce Committee approved BIO-supported legislation intended to increase transparency of the business practices of pharmacy benefit managers (PBMs), which can …
Senate Committee advances PBM transparency legislation Read More »
The Biotechnology Innovation Organization (BIO) is proud to celebrate Pride Month, which, in many places, is returning to in-person celebrations for the first time since …
Pride Month is back in person – here’s how biotech is celebrating Read More »
The World Trade Organization (WTO) agreed to waive COVID vaccine intellectual property protections—and many stakeholders are upset about it. Yes, the COVID vaccine IP waiver …
The COVID vaccine IP waiver is not a good idea – here’s why Read More »
We can support the development of biotechnology that reduces the environmental footprint of chemical manufacturing by correctly defining sustainable chemistry, states the Biotechnology Innovation Organization …
The World Trade Organization (WTO) agreed to “a waiver of certain requirements concerning compulsory licensing for COVID-19 vaccines.” However, the waiver of COVID vaccine IP …
WTO agrees to COVID vaccine IP waiver – here’s what we know Read More »
Remarks from Paul Hastings, CEO of Nkarta Therapeutics and Chairman of the Biotechnology Innovation Organization (BIO), as prepared for delivery at the BIO International Convention …
We partnered with the Biotechnology Innovation Organization (BIO) in 2019 to develop comprehensive news content about the industry and a quick-read daily newsletter with the …
The COVID-19 pandemic brought anxiety and uncertainty worldwide, and also created challenges from social isolation to supply chain issues to economic instability, which worsened gender …
BIO Unbound: ‘Science is limitless when we limit science less’ Read More »
On Day 2, the Good Day BIO Live team brings you exclusive interviews with Johnson & Johnson’s Pierre Theodore, Travere Therapeutics’ Eric Dube, Organon’s Kevin Ali, and …
Good Day BIO LIVE! from San Diego – watch Tuesday’s episode Read More »
The biotechnology industry’s focus on diversity, equity, and inclusion (DEI) in recent years has brought about improvement, but we still have work to do, according …
Biotech leaders discuss how to build a more inclusive industry Read More »
In January 2020, BIO launched Good Day BIO, a daily morning newsletter with the day’s top biotech stories—in five minutes or less, and in pithy …
Good Day BIO LIVE! from San Diego – watch our first episode now Read More »
